Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Bain Capital GSS Investment Corp.

CIK: 20643551 Annual ReportLatest: 2026-03-20

10-K / March 20, 2026

BCSS

Overview

BCSS is a Cayman Islands exempted company organized on March 24, 2025 to effectuate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the initial business combination) with one or more businesses.

Sponsor and management

  • Sponsor: Bain Capital GSS Investment Sponsor LLC, a Delaware limited liability company. The sponsor is controlled by its controlling members and is affiliated with Bain Capital Special Situations (BCSS).
  • The sponsor and certain affiliates may hold founder shares and private placement units.
  • Company management and the board are established; the sponsor transferred 30,000 founder shares to each of three independent directors.

Capital structure and funds raised

  • Public offering: 46,000,000 units sold to the public at $10.00 per unit; the underwriter’s over-allotment option for 6,000,000 units was exercised in full.
  • Gross proceeds from the public offering: $460,000,000.
  • Private placement: 900,000 private placement units sold at $10.00 per unit; gross proceeds $9,000,000.
  • Total gross proceeds at closing: $469,000,000.
  • Trust account proceeds after paying $16,100,000 of deferred underwriting commissions: $443,900,000 available to complete an initial business combination.
  • Funds outside the trust at closing: approximately $1,300,000 for working capital and potential claims; the company may fund additional dissolution costs (up to about $100,000) from the trust or outside sources.
  • As of December 31, 2025: cash outside the trust was approximately $785,000; working capital deficit was approximately $15,199,198.

Founders, private placement, and dilution

  • Founders: 11,500,000 founder shares issued to the sponsor; sponsor transferred 30,000 founder shares to each of three independent directors.
  • Private placement: 900,000 private placement units issued to the sponsor simultaneously with the IPO.
  • The sponsor and independent directors own founder shares and private placement units; substantially all have agreed to waive redemption rights with respect to those interests in connection with the initial business combination.
  • The sponsor is expected to hold approximately 20% of the company’s ordinary shares on an as-converted basis after the IPO, subject to future purchases and other adjustments.

Public securities and listing

  • Units: BCSS.U (NYSE)
  • Class A ordinary shares: BCSS (NYSE)
  • Warrants: BCSS.W (NYSE)

Business model and timing

  • The company intends to use cash in the trust or other funds (equity, debt, or a combination) to complete the initial business combination.
  • The company may pursue targets in any industry or geography, with a focus on industries that complement the management team’s background and Bain Capital’s ecosystem.
  • Target identification may come from Bain’s network, unaffiliated sources (investment banks, private funds), and contacts of officers, directors, and their affiliates.
  • The company may engage finders or third parties in connection with a potential business combination; fees to finders are payable only upon completion.

Management and staffing

  • The company currently has three executive officers and intends to operate with a lean staff prior to completing a business combination.
  • Officers and directors may continue in various roles after a transaction and some may enter employment or consulting arrangements with the post-combination company.

Targeting and industry focus

  • The company has not selected a specific target and is open to opportunities across industries and geographies.
  • Management expects that Bain’s sourcing capabilities and the sponsor’s infrastructure will support deal flow and due diligence.

Governance, protections, and timeline

  • Public shareholders may redeem their Class A shares for cash at the closing of the initial business combination, subject to the conditions set forth in the governing documents and the amount of funds in the trust.
  • Redemption mechanics depend on whether the company seeks shareholder approval or uses tender offer mechanics; procedures and thresholds are described in the offering materials.
  • Private placement units and their underlying securities do not have redemption rights.
  • Founder shares convert 1-for-1 to Class A ordinary shares at the time of the business combination; anti-dilution features may affect public holders.
  • The company has a contemplated 36-month window to complete the initial business combination, with possible extensions by shareholder approval (subject to redemption rights and other terms).
  • If no business combination is completed within the window, the company will liquidate, redeem public shares in cash, and warrants will expire worthless.
  • The company’s governing documents designate the courts of the Cayman Islands as the exclusive forum for certain disputes, with carve-outs for federal securities claims.

Regulatory and risk considerations

  • The 2024 SEC SPAC rules and related changes could affect disclosures, accounting, and the deal process.
  • There is a possibility the company could be considered an investment company under the Investment Company Act, which would impose additional regulatory requirements.
  • National security reviews, including CFIUS, could affect transactions involving U.S.-based targets; sponsor affiliations could prompt foreign ownership considerations.
  • There is no guarantee the company will complete a business combination within the prescribed window. Failure to complete a business combination could result in liquidation and distribution of trust assets to redeeming shareholders, which could be less than $10.00 per share if creditors’ claims reduce the trust.

Summary takeaway

BCSS is a Bain Capital–backed SPAC formed to pursue an initial business combination using proceeds from its IPO and private placement. It maintains a substantial trust fund intended to enable cash redemptions for public shareholders at closing or upon liquidation. The company will source opportunities through Bain’s network, unaffiliated intermediaries, and contacts of management and the sponsor, and it operates with a lean pre-combination staff. Governance provisions and shareholder rights are structured to balance sponsor influence with protections for public shareholders.